CMTA-STAR Biotech & Alliance PartnersSince 2008, STAR has invested more than $17 million in CMT research. Currently, the STAR Drug Development Pipeline involves more than 30 research partners in more than 50 research studies.
The Spring 2021 CMTA ReportInside: Every aspect of CMTA-STAR from cross-type initiatives to our demyelinating and axonal research portfolios to clinical trial readiness—and so much more.
$500,000 CMT1A Challenge MatchDeveloping therapeutics for CMT1A requires major funding, so we are extremely grateful to Seth and Missy Warfield, who hope to raise $1 Million and will match all donations to their CMT1A Challenge up to $500,000.
Accelerate Clinical Trials in Charcot-Marie-Tooth Disease (ACT-CMT)To help us prepare for clinical trials, this study is to determine the best way to measure the progression of CMT Type 1A.
Coronavirus (COVID-19) and CMTNew! Update on COVID-19 vaccines and CMT, plus more information about the coronavirus, which may have more of an impact on people who are at higher risk of infection.
What is CMT?
Find a Local Branch
Find a CMTA Branch Near You
With over 70 branches across the United States and two in Canada the CMTA helps connect patients to local resources.
Make a Difference,
Support CMT Research
Currently, there is no cure for CMT, but we can change that with your support. Donate now and help us accelerate research to develop treatments and a cure for CMT.Donate